Disaster Preparedness: What We Have Learned and Where We Need To Go (101)

What We Have Learned and What We Need to Know

s and Treatment Recommendations Abstract: Stem Cell Transplantation in the Therapy of ALL in Children [1] Evidence supporting the role of hematopoietic stem cell transplantation (SCT) in the therapy of acute Table 1. Grading the Quality of Design and Strength of Evidence Stem Cell Transplantation in the Therapy of ALL in Children [1] Evidence supporting the role of hematopoietic stem cell trans...

What Have We Learned and Where Are We Headed?

As a result of technological advances, the genomic analysis of stroke has shifted from candidate gene association studies to genome-wide association studies (GWAS). Agnostic GWAS evaluate up to 90% of common genetic variation in a single experiment, creating an improved framework for identifying novel genetic leads for biochemical and cellular mechanisms underlying stroke. Given the ubiquity of...

What have we learned, and where do we go from here?

S17(0), has now been measured with high precision (±5% or better) by different groups and good agreement is found, even when very different methods are employed. We review the decade long research program to measure the cross section of the Be(p, γ)B reaction using the Coulomb dissociation method, including the pioneering RIKEN1 experiment carried out during March 1992, followed by RIKEN2, GSI1...

Exercise and Duchenne muscular dystrophy: where we have been and where we need to go.

EXERCISE AND DUCHENNE MUSCULAR DYSTROPHY: WHERE WE HAVE BEEN AND WHERE WE NEED TO GO CHAD D. MARKERT, PhD, LAURA E. CASE, DPT, PCS, GREGORY T. CARTER, MD, MS, PATRICIA A. FURLONG, RN, BSN, MS, and ROBERT W. GRANGE, PhD Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA Division of Physical Therapy, Department of Community and Family...

Foreclosure P Roceedings : Where We Have Been and Where We Need to Go